PROS1 and Alzheimer disease: Differences in the proportional abundance of staphylococcal species between AD patients and healthy individuals likely reflect pathophysiological abnormalities in AD skin with immune activation and decreased expression of skin barrier proteins, creating niches that facilitate different staphylococcal communities.